“Are you Diabetic? It’s Your Heart…Protect It”, a nation-wide consumer awareness drive is set to kick off with the aim of creating a holistic understanding on the link between type 2 diabetes, cardiovascular diseases (CVDs) and associated risks
- According to the International Diabetes Federation (IDF), there were 585,400 cases of diabetes in 2017 and 47% of deaths in Lebanon are due to cardiovascular disease
- Type 2 Diabetes has a major public health impact through high disease prevalence in Lebanon, significant downstream pathophysiologic effects, and enormous financial liabilities
Beirut, Lebanon – 28th September, 2018: Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, officially marked World Heart Day in Lebanon, in an effort to raise awareness on the important link between CVDs and type 2 diabetes.
During a press conference, the company launched its nationwide awareness drive, “Are you Diabetic? It’s Your Heart…Protect It”, by joining forces with the Lebanese Society of Endocrinology, Diabetes and Lipid (LSEDL) as well as the Lebanese Society of Cardiology (LSC) to address patient compliance and adherence to type 2 diabetes treatments and the overall management of CVD implications related to type 2 diabetes.
The campaign will also include a consumer drive, where Beirut by Bike, a progressive bike club founded to promote the concept of biking for a healthy living, will organize a public event on the 29th September that will include healthcare professionals, members of the local media, and the general public.
The panel members at the press conference acknowledged that patient knowledge of CVDs in Lebanon is minimal, and there is an urgent need to work closely with diabetologists and government bodies, to drive better outcomes for the general population, which has a high profile of cardiovascular risk factors.